The Effectiveness of Emotional Disclosure on Depression, Anxiety and Stress and Quality of Life in Women after Abortio
- Conditions
- Condition 1: depression. Condition 2: anxiety. Condition 3: stress.Major depressive disorder, single episode, mildGeneralized anxiety disorderAcute stress reactionF32.0F41.1F43.0
- Registration Number
- IRCT20210528051421N1
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 70
1-Women who have had a miscarriage within 48-24 hours.
2- Will be willing to participate in the study and complete the informed consent form.
3- Be a Muslim and an Iranian.
4- To be 18-45 years old.
5- Pregnancy is the desire of the couple.
6- Does not have chronic physical diseases.
7 - Do not have a disability.
8- Has no other psychological disorders.
9- Be literate.
10- Do not have major stressful events in the last 6 months.
11- Has not taken sedatives and psychotropic drugs in the last 6 months.
12- Not addicted to drugs, tobacco and alcohol.
13- Have a spouse and live with his.
14- Has no history of infertility.
15- Depression score between 10-20 (mild and moderate depression) has been obtained from the Depression, Anxiety and Stress Questionnaire 21-DASS.
16- Anxiety score higher than 7 (mild anxiety up) has been obtained from the Depression, Anxiety and Stress Questionnaire 21-DASS.
17- Stress score higher than 14 (mild stress upwards) has obtained from the Depression, Anxiety and Stress Questionnaire 21-DASS.
Unable to write, speak or listen.
Have severe physical complications from abortion.
Do not have access to a mobile phone.
Be pregnant with assisted reproductive techniques.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Depression score in Anxiety, Stress, Depression Questionnaire (DASS -21). Timepoint: Before the intervention, end of the intervention and one month after the intervention. Method of measurement: Anxiety, stress, depression questionnaire ( DASS -21).;Anxiety score in Anxiety, Stress, Depression Questionnaire (DASS -21). Timepoint: Before the intervention, end of the intervention and one month after the intervention. Method of measurement: Anxiety, stress, depression questionnaire ( DASS -21).;Stress score in Anxiety, Stress, Depression Questionnaire (DASS -21). Timepoint: Before the intervention, end of the intervention and one month after the intervention. Method of measurement: Anxiety, stress, depression questionnaire ( DASS -21).;Quality of life score in the World Health Organization quality of life questionnaire. Timepoint: Before the intervention, end of the intervention and one month after the intervention. Method of measurement: World Health Organization Quality of Life Questionnaire - Short Form.
- Secondary Outcome Measures
Name Time Method